Baroda BNP Paribas Mid Cap Fund
(An Open ended Equity Scheme predominantly investing
in mid cap stocks)
Baroda BNP Paribas Mid Cap Fund
(An Open ended Equity Scheme predominantly investing
in mid cap stocks)
December 2024

December 2024


Investment Objective

The investment objective of the Scheme seeks to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the mid capitalization segment. The fund will emphasize on companies that appear to offer opportunities for longterm growth and will be inclined towards companies that are driven by dynamic style of management and entrepreneurial flair. However, there can be no assurance that the investment objectives of the Scheme will be realized. The Scheme does not guarantee/indicate any returns.

NAV Details (As on December 31, 2024)
Regular Plan - Growth Option : ₹63.7998
Regular Plan - IDCW Option : ₹102.2968
Direct Plan - Growth Option : ₹80.0138
Direct Plan - IDCW Option : ₹120.8116
Benchmark Index (Tier 1)

Nifty Midcap 150 TRI

Date of Allotment

May 02, 2006

Fund Manager
Fund Manager Managing fund since Experience
Shiv Chanani 13-Jul-22 24 years
Mr. Himanshu Singh 21-Oct-24 10 years

Load Structure

Exit Load: Within 12 months • Redeemed or switched out upto 10% of the allotment: Nil Redeemed or switched out more than 10% from the date of allotment : 1% After 12 months - Nil
For detailed load structure please refer Scheme Information Document of the scheme.


Lumpsum Details

Minimum Application Amount:
₹ 5,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on December 31, 2024 : ₹ 2,189.23 Crores
AUM## As on December 31, 2024 : ₹ 2,186.47 Crores

## excluding inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS% of Net Assets
Pharmaceuticals & Biotechnology 10.38%
Lupin Limited 2.32%
Alkem Laboratories Limited 2.06%
IPCA Laboratories Limited 1.94%
Abbott India Limited 1.77%
GlaxoSmithKline Pharmaceuticals Limited 1.29%
Zydus Lifesciences Limited 1.00%
Finance 8.96%
CRISIL Limited 3.04%
Sundaram Finance Limited 1.76%
LIC Housing Finance Limited 1.48%
Mahindra & Mahindra Financial Services Limited 1.39%
Poonawalla Fincorp Limited 1.29%
Electrical Equipment 7.24%
Hitachi Energy India Limited 2.85%
GE Vernova T&D India Limited 2.14%
Thermax Limited 1.20%
Bharat Heavy Electricals Limited 1.05%
Auto Components 6.41%
Schaeffler India Limited 1.40%
Bosch Limited 1.40%
ZF Commercial Vehicle Control Systems India Limited 1.37%
Exide Industries Limited 1.24%
Jtekt India Limited 1.00%
Banks 4.23%
The Federal Bank Limited 2.29%
Indian Bank 1.94%
Consumer Durables 4.06%
Dixon Technologies (India) Limited 2.67%
Metro Brands Limited 1.39%
Financial Technology (Fintech) 3.86%
PB Fintech Limited 3.86%
Industrial Products 3.43%
Ratnamani Metals & Tubes Limited 1.45%
AIA Engineering Limited 1.01%
Supreme Industries Limited 0.97%
Agricultural, Commercial & Construction Vehicles 2.89%
Escorts Kubota Limited 1.83%
Ashok Leyland Limited 1.06%
Automobiles 2.89%
TVS Motor Company Limited 1.86%
Ola Electric Mobility Ltd 1.03%
Leisure Services 2.81%
The Indian Hotels Company Limited 2.81%
Insurance 2.27%
ICICI Prudential Life Insurance Company Limited 1.29%
ICICI Lombard General Insurance Company Limited 0.98%
Realty 2.24%
The Phoenix Mills Limited 2.24%
Fertilizers & Agrochemicals 2.21%
Coromandel International Limited 1.20%
PI Industries Limited 1.01%
Retailing 2.17%
Info Edge (India) Limited 1.19%
Trent Limited 0.98%
Non - Ferrous Metals 2.13%
National Aluminium Company Limited 2.13%
Chemicals & Petrochemicals 2.01%
Navin Fluorine International Limited 1.04%
Deepak Nitrite Limited 0.97%
IT - Software 1.88%
HCL Technologies Limited 1.01%
KPIT Technologies Limited 0.87%
Telecom - Services 1.64%
Indus Towers Limited 1.64%
Healthcare Services 1.32%
Max Healthcare Institute Limited 1.32%
Personal Products 1.24%
Procter & Gamble Hygiene and Health Care Limited 1.24%
Petroleum Products 1.23%
Hindustan Petroleum Corporation Limited 1.23%
Cement & Cement Products 1.22%
JK Lakshmi Cement Limited 1.22%
Textiles & Apparels 1.09%
Page Industries Limited 1.09%
IT - Services 1.06%
Inventurus Knowledge Solutions Limited 1.06%
Power 1.05%
NLC India Limited 1.05%
Gas 1.03%
Petronet LNG Limited 1.03%
Beverages 1.02%
United Breweries Limited 1.02%
Industrial Manufacturing 1.00%
Cochin Shipyard Limited 1.00%
Oil 0.99%
Oil India Limited 0.99%
Diversified 0.97%
3M India Limited 0.97%
Food Products 0.97%
Hatsun Agro Product Limited 0.97%
Minerals & Mining 0.90%
NMDC Limited 0.90%
LESS THAN 0.75% EXPOSURE 1.88%
FUTURES LONG POSITION 3.29%
Oracle Financial Services Software Limited 2.32%
Voltas Limited 0.97%
TOTAL EQUITY HOLDINGS 93.97%
FIXED INCOME HOLDINGS Rating of Net Assets
TREASURY BILL 1.36%
182 Days Tbill (MD 14/02/2025) Sovereign 0.91%
364 Days Tbill (MD 27/02/2025) 0.45%
Total Fixed Income Holdings 1.36%
TREPS, Cash & Other Net Current Assets 4.67%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 26.54% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here


Pursuant to distribution under Income Distribution cum Capital Withdrawal (‘IDCW’) option, NAV of the IDCW option of the scheme(s) would fall to the extent of payout and statutory levy (if applicable). The amounts under IDCW options can be distributed out of investors capital (Equalization Reserve), which is part of sale price that represents realized gains. Past performance may or may not be sustained in future. The above stated distribution rate per unit is net distribution rate after deducting applicable taxes. The above distribution rates are on face value of ₹ 10 per unit.

TER - Regular Plan (%) 1.99%
TER - Direct Plan (%) 0.56%
Portfolio Turnover Ratio 0.84
Standard Deviation*†† 12.97%
Beta*†† 0.80
Sharpe Ratio*†† 1.07
Sharpe Ratio (annualised), Standard Deviation (annualised) and Beta are based on last 36 monthly data points.
†† The scheme is a ‘Transferee Scheme’, and accordingly, the ratios are being provided considering the weighted average NAVs of both the Transferor Scheme and Transferee Scheme.

* The information contained in this report has been obtained from sources considered to be authentic and reliable. This quantitative data does not purport to be an offer for purchase and sale of mutual fund units. The risk free rate of return considered for calculation of Sharpe ratio is 7.15%, as per 1 day MIBOR rate on the last business day of the month.

No of Stocks 66
Portfolio RoE (%) 17.12
EPS Growth (%) 46.58

Portfolio RoE and EPS Growth is for trailing 12 months (TTM) whereas the number of stocks is as of December 31, 2024.
This product is suitable for investors who are seeking*:

➤ Wealth Creation in long term.
➤ Investments in companies in mid capitalization segment.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty Midcap 150 TRI): basis it’s constituents; As on December 31, 2024

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.